clostridia strain formulation ve303
Generic: Clostridia Strain Formulation VE303
clostridia strain formulation ve303: 1 clinical trial tracked.
clostridia strain formulation ve303 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about clostridia strain formulation ve303, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Primary endpoint: CDI Recurrence Rate at Week 8
InterventionalRandomizedquadruple852 targetStarted 2024-05Completion 2027-1050 sites · United StatesVedanta Biosciences, Inc.